(MO) Altria - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US02209S1033

Stock:

Total Rating 65
Risk 94
Buy Signal 0.53
Risk 5d forecast
Volatility 19.7%
Relative Tail Risk -6.56%
Reward TTM
Sharpe Ratio 1.30
Alpha 32.29
Character TTM
Beta -0.036
Beta Downside 0.218
Drawdowns 3y
Max DD 16.40%
CAGR/Max DD 1.41

EPS (Earnings per Share)

EPS (Earnings per Share) of MO over the last years for every Quarter: "2020-12": 0.99, "2021-03": 1.07, "2021-06": 1.23, "2021-09": 1.22, "2021-12": 1.09, "2022-03": 1.12, "2022-06": 1.26, "2022-09": 1.28, "2022-12": 1.18, "2023-03": 1.18, "2023-06": 1.31, "2023-09": 1.28, "2023-12": 1.18, "2024-03": 1.15, "2024-06": 1.31, "2024-09": 1.38, "2024-12": 1.29, "2025-03": 1.23, "2025-06": 1.44, "2025-09": 1.45, "2025-12": 1.3,

Revenue

Revenue of MO over the last years for every Quarter: 2020-12: 5055, 2021-03: 4880, 2021-06: 5614, 2021-09: 5531, 2021-12: 5086, 2022-03: 4819, 2022-06: 5374, 2022-09: 5412, 2022-12: 5083, 2023-03: 4763, 2023-06: 5438, 2023-09: 5277, 2023-12: 5024, 2024-03: 4717, 2024-06: 5277, 2024-09: 5344, 2024-12: 5106, 2025-03: 4519, 2025-06: 5290, 2025-09: 5251, 2025-12: 5846,

Description: MO Altria

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income: 6.95b TTM > 0 and > 6% of Revenue
FCF/TA: 0.26 > 0.02 and ΔFCF/TA 1.43 > 1.0
NWC/Revenue: -17.27% < 20% (prev -20.88%; Δ 3.61% < -1%)
CFO/TA 0.27 > 3% & CFO 9.29b > Net Income 6.95b
Net Debt (21.23b) to EBITDA (10.70b): 1.98 < 3
Current Ratio: 0.61 > 1.5 & < 3
Outstanding Shares: last quarter (1.68b) vs 12m ago -1.00% < -2%
Gross Margin: 69.56% > 18% (prev 0.70%; Δ 6886 % > 0.5%)
Asset Turnover: 59.57% > 50% (prev 58.12%; Δ 1.45% > 0%)
Interest Coverage Ratio: 9.70 > 6 (EBITDA TTM 10.70b / Interest Expense TTM 1.08b)

Altman Z'' 6.52

A: -0.10 (Total Current Assets 5.54b - Total Current Liabilities 9.15b) / Total Assets 35.02b
B: 1.01 (Retained Earnings 35.45b / Total Assets 35.02b)
C: 0.30 (EBIT TTM 10.47b / Avg Total Assets 35.10b)
D: 1.80 (Book Value of Equity 69.21b / Total Liabilities 38.47b)
Altman-Z'' Score: 6.52 = AAA

Beneish M -3.13

DSRI: 0.95 (Receivables 263.0m/270.0m, Revenue 20.91b/20.44b)
GMI: 1.01 (GM 69.56% / 70.27%)
AQI: 0.96 (AQ_t 0.79 / AQ_t-1 0.83)
SGI: 1.02 (Revenue 20.91b / 20.44b)
TATA: -0.07 (NI 6.95b - CFO 9.29b) / TA 35.02b)
Beneish M-Score: -3.13 (Cap -4..+1) = AA

What is the price of MO shares?

As of February 25, 2026, the stock is trading at USD 68.98 with a total of 7,151,057 shares traded.
Over the past week, the price has changed by +3.67%, over one month by +11.42%, over three months by +22.52% and over the past year by +33.80%.

Is MO a buy, sell or hold?

Altria has received a consensus analysts rating of 3.27. Therefor, it is recommend to hold MO.
  • StrongBuy: 3
  • Buy: 1
  • Hold: 9
  • Sell: 1
  • StrongSell: 1

What are the forecasts/targets for the MO price?

Issuer Target Up/Down from current
Wallstreet Target Price 63.9 -7.3%
Analysts Target Price 63.9 -7.3%

MO Fundamental Data Overview February 21, 2026

P/E Trailing = 16.2267
P/E Forward = 11.7371
P/S = 5.6673
P/B = 27.3016
P/EG = 4.0147
Revenue TTM = 20.91b USD
EBIT TTM = 10.47b USD
EBITDA TTM = 10.70b USD
Long Term Debt = 24.14b USD (from longTermDebt, last quarter)
Short Term Debt = 1.57b USD (from shortTermDebt, last quarter)
Debt = 25.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.23b USD (from netDebt column, last quarter)
Enterprise Value = 135.37b USD (114.13b + Debt 25.71b - CCE 4.47b)
Interest Coverage Ratio = 9.70 (Ebit TTM 10.47b / Interest Expense TTM 1.08b)
EV/FCF = 14.92x (Enterprise Value 135.37b / FCF TTM 9.07b)
FCF Yield = 6.70% (FCF TTM 9.07b / Enterprise Value 135.37b)
FCF Margin = 43.40% (FCF TTM 9.07b / Revenue TTM 20.91b)
Net Margin = 33.23% (Net Income TTM 6.95b / Revenue TTM 20.91b)
Gross Margin = 69.56% ((Revenue TTM 20.91b - Cost of Revenue TTM 6.36b) / Revenue TTM)
Gross Margin QoQ = 62.11% (prev 72.60%)
Tobins Q-Ratio = 3.87 (Enterprise Value 135.37b / Total Assets 35.02b)
Interest Expense / Debt = 1.03% (Interest Expense 264.0m / Debt 25.71b)
Taxrate = 26.17% (396.0m / 1.51b)
NOPAT = 7.73b (EBIT 10.47b * (1 - 26.17%))
Current Ratio = 0.61 (Total Current Assets 5.54b / Total Current Liabilities 9.15b)
Debt / Equity = -7.34 (negative equity) (Debt 25.71b / totalStockholderEquity, last quarter -3.50b)
Debt / EBITDA = 1.98 (Net Debt 21.23b / EBITDA 10.70b)
Debt / FCF = 2.34 (Net Debt 21.23b / FCF TTM 9.07b)
Total Stockholder Equity = -3.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.79% (Net Income 6.95b / Total Assets 35.02b)
RoE = -215.2% (negative equity) (Net Income TTM 6.95b / Total Stockholder Equity -3.23b)
RoCE = 50.06% (EBIT 10.47b / Capital Employed (Equity -3.23b + L.T.Debt 24.14b))
RoIC = 34.57% (NOPAT 7.73b / Invested Capital 22.36b)
WACC = 4.86% (E(114.13b)/V(139.84b) * Re(5.78%) + D(25.71b)/V(139.84b) * Rd(1.03%) * (1-Tc(0.26)))
Discount Rate = 5.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.61%
[DCF Debug] Terminal Value 86.69% ; FCFF base≈8.89b ; Y1≈9.22b ; Y5≈10.49b
Fair Price DCF = 173.5 (EV 311.76b - Net Debt 21.23b = Equity 290.53b / Shares 1.67b; r=5.90% [WACC]; 5y FCF grow 3.86% → 2.90% )
EPS Correlation: 60.03 | EPS CAGR: 4.05% | SUE: -0.36 | # QB: 0
Revenue Correlation: 17.35 | Revenue CAGR: 5.29% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.24 | Chg30d=-0.012 | Revisions Net=-5 | Analysts=8
EPS current Year (2026-12-31): EPS=5.59 | Chg30d=-0.003 | Revisions Net=+0 | Growth EPS=+3.1% | Growth Revenue=+0.4%
EPS next Year (2027-12-31): EPS=5.81 | Chg30d=+0.002 | Revisions Net=+3 | Growth EPS=+4.0% | Growth Revenue=+0.4%

Additional Sources for MO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle